Hepatitis C: Clinical sciences

1,190views

test

00:00 / 00:00

Hepatitis C: Clinical sciences

Focused chief complaint

Abdominal pain

Approach to biliary colic: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Acute coronary syndrome: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Adnexal torsion: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Aortic dissection: Clinical sciences
Appendicitis: Clinical sciences
Approach to ascites: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Chronic pancreatitis: Clinical sciences
Colonic volvulus: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Diverticulitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Endometriosis: Clinical sciences
Gastritis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Ileus: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inguinal hernias: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Lower urinary tract infection: Clinical sciences
Malaria: Clinical sciences
Nephrolithiasis: Clinical sciences
Paraesophageal and hiatal hernia: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pulmonary embolism: Clinical sciences
Pyelonephritis: Clinical sciences
Rectus sheath hematoma: Clinical sciences
Retroperitoneal hematoma: Clinical sciences
Sickle cell disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences

Altered mental status

Approach to altered mental status: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Alcohol withdrawal: Clinical sciences
Approach to encephalitis: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to hypocalcemia: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to schizophrenia spectrum and other psychotic disorders: Clinical sciences
Approach to shock: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Delirium: Clinical sciences
Diabetic ketoacidosis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Hypothermia: Clinical sciences
Hypovolemic shock: Clinical sciences
Lower urinary tract infection: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Pyelonephritis: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Substance use disorder: Clinical sciences
Uremic encephalopathy: Clinical sciences

Assessments

USMLE® Step 2 questions

0 / 4 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

A 62-year-old man presents to the gastroenterology clinic for follow-up of chronic hepatitis C. Four weeks ago, the patient was diagnosed with chronic hepatitis C infection and was started on sofosbuvir-velpatasvir. The patient has no significant past medical history and takes no medications. He drinks a few beers during the week and 5-6 beers on the weekends. AST, ALT, and total bilirubin were mildly elevated at that time. On today’s visit, the patient is feeling well and has more energy since starting treatment. Temperature is 37.0 ºC (98.6 ºF), pulse is 78/min, blood pressure is 110/71 mmHg, respiratory rate is 12/min, and SpO2 is 100% on room air. Repeat AST, ALT, and total bilirubin levels have significantly improved. Which of the following is the best next step in management?  

Transcript

Watch video only

Hepatitis C virus, or HCV for short, is a bloodborne viral infection that’s typically transmitted through contaminated blood, or sexual contact. Once inside the body, hepatitis C virus circulates through the blood, eventually reaching the liver, where it infects hepatocytes. Acute hepatitis C infections are usually asymptomatic, but if the virus sticks around long enough in the body, acute infection can progress to chronic infection, which can lead to the development of cirrhosis, and even hepatocellular carcinoma.

Now, if you suspect hepatitis C infection, first perform an ABCDE assessment to determine if your patient is unstable or stable.

If unstable, your patient may present with alarming signs and symptoms, such as altered mental status, asterixis, upper GI hemorrhage, and ascites. In this case, immediately stabilize their airway, breathing, and circulation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, and pulse oximetry.

Here’s a clinical pearl to keep in mind! These findings can be seen in individuals with fulminant hepatitis, often referred to as acute liver failure, which is most often caused by viral hepatitis or acetaminophen overdose. Lab findings suggestive of fulminant hepatitis include elevated transaminases like AST and ALT, as well as elevated PT/INR and serum bilirubin. It’s important to recognize these patients on time, and once stable, refer them to a liver transplant center for further management!

Ok, let’s go back to the ABCDE assessment and take a look at stable individuals.

If the patient is instead stable, obtain a focused history and physical examination. History typically reveals symptoms such as fatigue, anorexia, low-grade fever, as well as nausea and vomiting. Additionally, your patient might report right upper quadrant abdominal pain and difficulty sleeping.

Finally, history might be positive for IV substance use, needlestick injury, sexual intercourse without protection, or receiving a non-sterile tattoo.

On the other hand, physical exam typically reveals jaundice and abdominal tenderness, while sometimes you might notice inflammatory skin changes, like psoriasis or urticaria, as well as signs consistent with thrombocytopenia, such as petechiae.

Your next step is to order labs, such as CMP, PT/INR, and PTT, which may reveal either elevated or normal AST and ALT, bilirubin, PT/INR, and PTT. These lab findings, in combination with your patient’s signs and symptoms, should lead you to suspect hepatitis C infection. Keep in mind that many patients with HCV are asymptomatic, so they may come to clinical attention on routine lab evaluation.

Let’s look at patients with positive HCV antibody tests.

Once you suspect hepatitis C infection, you should order an HCV antibody test to determine whether or not your patient has HCV antibodies. If the HCV antibody test is positive, obtain an HCV RNA test to assess the viral load, or in other words, how much of the HCV is in the patient’s blood. As a side note, many labs will reflexively send the HCV RNA test if the HCV antibody is positive. So, if the HCV RNA test does not detect viral load, assess for risk factors, such as a history of HCV exposure in the last 6 months or history of immunocompromised status.

Now, here’s a clinical pearl to keep in mind! Patients that are HCV antibody positive with undetectable HCV RNA levels may have three possible clinical scenarios. Firstly, they might have been infected but cleared the infection spontaneously. Secondly, they may have had an HCV infection that was already treated with antiviral medication. And thirdly, the patient’s antibody test may be a false positive; in this case, if your suspicion is high based on clinical presentation, you should repeat HCV antibody test and order HCV RNA test within 6 months to rule out or confirm the diagnosis.

So back to assessing risk factors, no known exposure to the virus and no history of immunocompromised state mean that you should consider alternative diagnoses. However, if your patient reports HCV exposure or is immunocompromised, then you should repeat the HCV RNA test 6 months after the initial testing. If the HCV RNA test does not detect viral load after 6 months, you should consider alternative diagnoses. On the other hand, if the HCV RNA test detects viral load, you can confirm the diagnosis of acute or chronic hepatitis C.

Sources

  1. "Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Joint panel from the American Association of the Study of Liver Diseases and the Infectious Diseases Society of America. " HCV
  2. "Clinical manifestations, diagnosis, and treatment of acute hepatitis C virus infection in adults'" Uptodate
  3. "Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. J323:970." AMA (2020)
  4. "Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. 125:80." Gastroenterology (2003)